Medical Device News Magazine

ACC Latin America 2022 Together with CardioAcademic Focuses on Global Collaboration

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The American College of Cardiology and CardioAcademic will host ACC Latin America 2022 Together with CardioAcademic in Mexico City from September 10-11, 2022. The event will bring the Latin American cardiology community together to examine emerging trends and evidence-based strategies for the prevention and management of cardiovascular disease, as well as present exciting new research being done in the region.

ACC Vice President B. Hadley Wilson, MD, FACC, executive vice-chair at the Sanger Heart & Vascular Institute, and ACC Assembly of International Governors Past Chair Erick Alexanderson, MD, FACC, chairman of the Nuclear Cardiology Department at the Instituto Nacional de Cardiología “Ignacio Chávez” and director of CardioAcademic, will serve as co-chairs for the conference.

“ACC‘s vision is a world where science knowledge and innovation optimize cardiovascular care and outcomes and what better way than getting together at ACC Latin America regional conference paired with CardioAcademic in Mexico City,” Wilson said. “These are two great meeting venues joined together for the best Latin America regional conference with cardiovascular thought leaders, along with other leaders in the Americas creating a dynamic exchange of leading-edge knowledge and practical networking. We’re sure attendees will find plenty to take home and put into practice for their patients.”

Valentin Fuster, MD, PhD, MACC, editor-in-chief of the Journal of the American College of Cardiology, will present the Opening Plenary Session, “New Frontiers in Cardiovascular Health: From the Heart to the Brain.” Other key sessions will examine the top cardiovascular complications of COVID-19, beginning primary prevention of heart disease through childhood education and the care of cardio-oncology patients. In addition to in-person sessions, the conference will feature a hybrid option with attendees having access to all virtual content.

Learn more about the conference at ACC.org/LatinAmerica2022.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”